BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29932238)

  • 1. ERβ targets ZAK and attenuates cellular hypertrophy via SUMO-1 modification in H9c2 cells.
    Pai P; Shibu MA; Chang RL; Yang JJ; Su CC; Lai CH; Liao HE; Viswanadha VP; Kuo WW; Huang CY
    J Cell Biochem; 2018 Sep; 119(9):7855-7864. PubMed ID: 29932238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
    Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
    Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage.
    Hsieh DJ; Kuo WW; Lai YP; Shibu MA; Shen CY; Pai P; Yeh YL; Lin JY; Viswanadha VP; Huang CY
    Cell Physiol Biochem; 2015; 36(1):274-84. PubMed ID: 25967966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling.
    Tsai CY; Kuo WW; Shibu MA; Lin YM; Liu CN; Chen YH; Day CH; Shen CY; Viswanadha VP; Huang CY
    PLoS One; 2017; 12(9):e0184153. PubMed ID: 28863192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis.
    Lin KH; Kuo WW; Shibu MA; Day CH; Hsieh YL; Chung LC; Chen RJ; Wen SY; Viswanadha VP; Huang CY
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
    Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner.
    Yang JJ; Lee YJ; Hung HH; Tseng WP; Tu CC; Lee H; Wu WJ
    Cancer Sci; 2010 Jun; 101(6):1374-81. PubMed ID: 20331627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
    Huang Q; Zhang Z; Liao Y; Liu C; Fan S; Wei X; Ai B; Xiong J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):133. PubMed ID: 29970138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.
    Huang CY; Kuo WW; Chueh PJ; Tseng CT; Chou MY; Yang JJ
    Biochem Biophys Res Commun; 2004 Nov; 324(1):424-31. PubMed ID: 15465036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.
    Rey C; Faustin B; Mahouche I; Ruggieri R; Brulard C; Ichas F; Soubeyran I; Lartigue L; De Giorgi F
    Oncogene; 2016 Jun; 35(24):3190-200. PubMed ID: 26522728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
    Bhavnani BR; Tam SP; Lu X
    Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.
    Cheng YC; Kuo WW; Wu HC; Lai TY; Wu CH; Hwang JM; Wang WH; Tsai FJ; Yang JJ; Huang CY; Chu CH
    Mol Cell Biochem; 2009 May; 325(1-2):69-77. PubMed ID: 19184368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells.
    Huang CY; Chueh PJ; Tseng CT; Liu KY; Tsai HY; Kuo WW; Chou MY; Yang JJ
    Biochem Biophys Res Commun; 2004 Nov; 324(3):973-80. PubMed ID: 15485649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.
    Pedram A; Razandi M; Lubahn D; Liu J; Vannan M; Levin ER
    Endocrinology; 2008 Jul; 149(7):3361-9. PubMed ID: 18372323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents.
    Hoa N; Ge L; Korach KS; Levin ER
    Mol Cell Endocrinol; 2018 Jul; 470():240-250. PubMed ID: 29127073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
    Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
    J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E
    Chang-Lee SN; Hsu HH; Shibu MA; Ho TJ; Tsai CH; Chen MC; Tu CC; Viswanadha VP; Kuo WW; Huang CY
    Pathol Oncol Res; 2017 Jul; 23(3):477-485. PubMed ID: 27757837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy.
    Du M; Huang K; Gao L; Yang L; Wang WS; Wang B; Huang K; Huang D
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):822-826. PubMed ID: 24337842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.